Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3020 |
|
Actual shortage: | 235 (8%) | |
Anticipated shortage: | 19 (1%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2757 (91%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
28 (10%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-ISMN | 60MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-03-10 | 2017-04-10 | 354 |
APO-ISMN | 60MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-05-02 | 2017-06-27 | 8602 |
APO-ISMN | 60MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-07-25 | 2018-02-23 | 16871 |
APO-ISMN | 60MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-07-25 | 2017-09-25 | 16874 |
APO-ISMN | 60MG | TABLET (EXTENDED-RELEASE) | Resolved | 2018-05-22 | 2018-08-09 | 50044 |
APO-ISMN | 60MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-02-26 | 2020-03-27 | 107199 |
APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Resolved | 2017-03-10 | 2017-04-24 | 345 |
APO-IRBESARTAN/HCTZ | 12.5MG 300MG | TABLET | Resolved | 2017-03-10 | 2017-04-24 | 351 |
APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Resolved | 2017-10-11 | 2017-11-15 | 25287 |
APO-IRBESARTAN | 150MG | TABLET | Resolved | 2017-03-10 | 2017-12-14 | 336 |
APO-IRBESARTAN | 300MG | TABLET | Resolved | 2017-03-10 | 2017-12-14 | 339 |
APO-IRBESARTAN | 75MG | TABLET | Resolved | 2017-03-10 | 2017-12-14 | 342 |
APO-IRBESARTAN | 300MG | TABLET | Resolved | 2018-05-15 | 2018-09-11 | 49408 |
APO-IRBESARTAN | 150MG | TABLET | Avoided shortage | 2018-07-15 | 2018-08-21 | 55788 |
APO-IRBESARTAN | 75MG | TABLET | Avoided shortage | 2018-07-15 | 2018-08-21 | 55791 |
APO-IRBESARTAN | 300MG | TABLET | Avoided shortage | 2018-07-15 | 2018-08-21 | 55810 |
APO-IRBESARTAN | 75MG | TABLET | Actual shortage | 2018-11-09 | 2018-11-09 | 66534 |
APO-IPRAVENT STERULES | 0.025% | SOLUTION | Actual shortage | 2017-08-13 | 2017-10-05 | 19060 |
APO-IPRAVENT STERULES | 125MCG | SOLUTION | Actual shortage | 2017-08-14 | 2017-10-05 | 19111 |
APO-INDAPAMIDE 2.5MG TABLETS | 2.5MG | TABLET | Resolved | 2023-08-04 | 2023-08-18 | 201168 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-SOLIFENACIN | 5MG | TABLET | Discontinued | 2019-03-11 | 2019-09-20 | 78272 |
APO-SIMVASTATIN | 10MG | TABLET | Discontinued | 2018-09-08 | 2018-12-28 | 60790 |
APO-SIMVASTATIN | 20MG | TABLET | Discontinued | 2018-09-08 | 2018-11-19 | 60793 |
APO-SILDENAFIL R | Discontinued | 2018-09-08 | 2018-09-15 | 60787 | ||
APO-SILDENAFIL | 100MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60784 |
APO-SERTRALINE | 100MG | CAPSULE | Discontinued | 2018-09-08 | 2018-09-15 | 60781 |
APO-SALVENT TABLETS - 4MG | 4MG | TABLET | Discontinued | 2018-02-23 | 2018-07-17 | 40847 |
APO-SALVENT TABLETS - 2MG | 2MG | TABLET | Discontinued | 2018-02-23 | 2018-12-28 | 40854 |
APO-ROSUVASTATIN | 10MG | TABLET | Discontinued | 2018-09-08 | 2019-07-13 | 60758 |
APO-ROSUVASTATIN | 10MG | TABLET | Discontinued | 2018-09-08 | 2019-02-13 | 60763 |
APO-ROSUVASTATIN | 20MG | TABLET | Discontinued | 2018-09-08 | 2018-12-28 | 60766 |
APO-ROSUVASTATIN | 40MG | TABLET | Discontinued | 2018-09-08 | 2019-02-13 | 60769 |
APO-ROSUVASTATIN | 40MG | TABLET | Discontinued | 2018-09-08 | 2019-08-08 | 60772 |
APO-ROSUVASTATIN | 5MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60775 |
APO-ROSUVASTATIN | 20MG | TABLET | Discontinued | 2018-09-08 | 2019-02-05 | 60778 |
APO-RIZATRIPTAN RPD | Discontinued | 2018-09-08 | 2019-04-02 | 60756 | ||
APO-RIZATRIPTAN RPD | Discontinued | 2019-01-04 | 2019-04-04 | 71334 | ||
APO-RISPERIDONE | 3.0MG | TABLET | Discontinued | 2018-09-08 | 2019-06-12 | 60750 |
APO-RISPERIDONE | 1MG | SOLUTION | To be discontinued | 2018-09-08 | 2018-09-08 | 60753 |
APO-RISPERIDONE | 1MG | SOLUTION | To be discontinued | 2019-03-11 | 2019-03-11 | 78260 |